Novel compound and pharmaceutically acceptable salt thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- HANGZHOU PUSH KANG BIOTECH CO LTD
- Publication Date
- 2020-09-29
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to the field of medicinal chemistry, in particular to a novel compound or a pharmaceutically acceptable salt thereof, wherein the compound includes a part derived from temozolomide and a part derived from elemene. Background technique
[0002] Elemene belongs to the sesquiterpenes. It is a natural medicine with clear anticancer activity extracted from the rhizome of Zingiberaceae Wenyujin (Ezhu) in China. It is a new type of anticancer drug. Elemene is mainly β-elemene, with a small amount of α-elemene, γ-elemene and δ-elemene. Elemene is a kind of volatile oil, so it has strong volatility and fat solubility. It is mainly used clinically for various cancers such as esophageal cancer, lung cancer, brain tumor, liver cancer, cervical cancer, cancerous chest, and cancer-related diseases. Symptoms (such as ascites). Among them, β-elemene is the main anti-cancer substance, and also has the functions of relieving cancer pain, ...